Genome Engineering Market to Clock CAGR of 10.9% from 2019 to 2027; CRISPR Gene Edition Tools Present Sizable Revenue Streams, TMR - Seite 3

Purchase the Genome Engineering Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=4671&ltype=S 

Global Genome Engineering Market: Segmentation

• Technology
• Clustered regularly interspaced short palindromic repeats (CRISPR)
• Transcription activator-like effector nuclease (Talen)
• Zinc Finger Nuclease (ZFN)
• Other Technologies
• Application
• Cell Line Engineering
• Animal Genome Engineering
• Plant Genome Engineering
• Other Application
• End-User
• Pharmaceutical and Biotechnology Companies
• Academics
• Clinical Research Organizations
• Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of Latin America
• Middle East & Africa
• GCC Countries

Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:

Active Pharmaceutical Ingredients (API) Market – According to Transparency Market Research's latest report on the global active pharmaceutical ingredients market for the historical period 2017–2018 and forecast period 2019–2027, increase in abbreviated new drug applications (ANDA) in the past few years and rise in government prioritization for biomedical innovation are projected to drive the global active pharmaceutical ingredients (API) market during the forecast period

Stem Cells Market – In the last few years, stem cells therapy has been gaining traction worldwide. A significant rise in the number of clinical application of stem cells and the advent of new treatments for chronic diseases are estimated to enhance the growth of the global stem cells market in the next few years. In addition to this, the rising investment by public as well as private organizations for research activities are likely to supplement the overall market growth in the near future.

Platelet-rich Plasma Market - According to the report, the global platelet-rich plasma market was valued at US$ 219.3 Mn in 2018 and is projected to expand at a CAGR of 11.4 % from 2019 to 2027. Increase in the number of orthopedic patients globally is considered a major factor fueling the growth of the global platelet-rich plasma market.